{
    "title": "113_hr5587",
    "content": "The Act may be cited as the \"Opioid Abuse Prevention and Treatment Act of 2014\". A pilot project is also included in the Act. The \"Opioid Abuse Prevention and Treatment Act of 2014\" includes a pilot project where the Secretary of Health and Human Services awards grants to States to develop a standardized peer review process for reviewing prescription drug monitoring programs. Recipients of the grant will investigate questionable prescribing and dispensing patterns of substances on schedule II or III under the Controlled Substances Act. The \"Opioid Abuse Prevention and Treatment Act of 2014\" authorizes grants to States for developing standardized peer review processes for prescription drug monitoring programs. States must provide information from the PDMP to regulators and licensing boards for controlled substances requiring DEA registration. Quality improvement organizations under contract with the Secretary may also be involved. The Social Security Act allows subgrantees to develop peer review processes under this subsection. SEC. 399V-6. PRESCRIPTION DRUG, HEROIN, AND OTHER CONTROLLED SUBSTANCE ABUSE PREVENTION is added to Part P of title III of the Public Health Service Act. The Secretary will award 5-year grants to eligible entities for training healthcare providers in patient screening, brief interventions, and referral to treatment to prevent abuse of prescription drugs, heroin, and other controlled substances. Eligible entities include States, physician organizations, and continuing education entities. The Secretary will award grants to States for evaluating expanding prescribing authorities of providers like advance practice nurses and physician's assistants for prescribing drugs to treat substance abuse. This includes peer recovery organizations and other health education institutions. The Secretary will award grants to States for developing continuing education criteria and review processes for safe prescribing of opioids and other drugs. The Attorney General will request practitioners to conduct patient screening for potential drug misuse before prescribing certain drugs. The FDA will review naloxone to potentially make it available over-the-counter to increase access. The Secretary will establish programs for drug disposal and limit opioid dispensing in emergency departments. The Comptroller General of the United States will review opioid and heroin abuse programs in Federal agencies and States, issuing a report to Congress with recommendations to reduce abuse and overdoses within 18 months of this Act's enactment."
}